Last edition
News about "progressive kidney disease"
Bayer Files Japan Application to Expand Finerenone Use in Non-Diabetic CKD
Bayer’s Japan filing, backed by Phase III FIND-CKD data showing slower kidney function decline and a 23 percent reduction in cardiovascular-kidney events, seeks to expand finerenone’s potential role in treating adults with non-diabetic CKD and addressing a significant unmet medical need.
Progressive Kidney Disease | 31/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members